
We are Pierre Fabre Laboratories, a global leader combining pharmaceutical expertise with dermo-cosmetics to support consumers and patients at every stage of their care journey.
Our portfolio includes several medical franchises and international brands such as Eau Thermale Avène, Ducray, A-Derma, Klorane, René Furterer, and Pierre Fabre Oral Care.
By joining us, you become part of a meaningful company where the human dimension is essential. You become a participant in the "We Care Movement," a movement that values excellence and innovation within passionate teams. Together, we push the boundaries of science to unite health and beauty for the benefit of all, because Every time we care for a single person, we make the whole world better.
Present in 120 countries with a team of over 10,000 employees, we are proud to create a scientific and human impact, today and tomorrow! If caring is at the heart of your values, join Pierre Fabre Laboratories and become a key player in the “We Care Movement".
We are recruiting a Bioprocess Expert in Antibody-Drug Conjugates (ADC) and next generation conjugates (“XDC” such as BsADCs, Dualpayload ADCs, AOCs…) for CMC on a permanent contract for our Toulouse site (Oncopole, 31), reporting to Pierre Fabre Pharma's R&D Department.
You will be responsible for the development of drug substance (ADC-DS) and manufacturing of new ADC and biologic drug candidates.
This includes the development, optimization, and characterization of bioprocesses for ADCs by defining and executing CMC strategy for these preclinical and clinical programs, ensuring robust, compliant manufacturing processes and high-quality clinical and commercial supplies.
Your role within a pioneering company in full expansion:
More specifically, you will:
This position is compatible with teleworking up to 2 days a week according to company rules.
We offer an attractive remuneration/benefits package: Incentives, profit-sharing, Pierre Fabre shareholding with matching contribution, health and provident insurance, 16 days of holidays (RTT) in addition to 25 days of personal holidays, public transport participation, very attractive CE...
Your skills at the service of innovative projects:
- Biochemical engineer or PhD in Biotechnology/Bioprocess
- Minimum 10 years' experience in bioprocess development for biologics with direct ADC experience (conjugation, linker-payload, HPAPI handling)
- Proven track record in CMC strategy through several clinical studies (phase 1 to phase 3) ideally up to registration, regulatory submissions, and interactions with health authorities.
- Strong knowledge of ICH guidelines, cGMP, and quality-by-design (QbD) concepts for biologics/ADCs
- Experience of technical leadership in bioprocess and project management associated with development programs is required.
- You have managed CDMOs
- Fluent English essential
- Excellent communication skills and ability to lead cross-functional CMC teams
At Pierre Fabre Laboratories, we believe that our greatest asset is our people.
We are committed to a policy of Equal Employment Opportunity and will not discriminate against an applicant or employee based on race, color, religion, creed, national origin or ancestry, sex, sexual orientation, gender identity or expression, age, physical or mental disability, veteran or military status, genetic information, or any other legally recognized protected basis under federal, state, or local law. The information collected by this application is solely to determine suitability for employment, verify identify, and maintain employment statistics on applicants. Applicants with disabilities may be entitled to reasonable accommodation under the Americans with Disabilities Act and certain state or local laws. Please inform the company’s personnel representative if you need assistance completing this application or to otherwise participate in the application process. Thus, we commit to considering all applications equally, without fail.

Laboratoires Pierre Fabre held by the Pierre Fabre Foundation, is a worldwide company with a unique positioning : the alliance of pharmaceutical and dermocosmetics expertise.
This makes Pierre Fabre Group :
💊 A pharmaceutical group with a strong positioning : medical and natural
🥈 The second largest dermo-cosmetics laboratory in the world
🥈 The second largest private French pharmaceutical group
🥇 The market leader in France for products sold over the counter in pharmacies.
Our portfolio includes several medical franchises and international brands including ;
Pharmaceutical Care
Pierre Fabre Oncologie
Pierre Fabre Dermatologie
Naturactive
Eau Thermale Avène
Klorane
Ducray
René Furterer
A-Derma
Pierre Fabre Oral Care
Glytone (US)
Darrow (Brasil)
Established in the Occitanie region since its creation, we manufacture over 95% of our products in France. We keep innovating passionately with our teams in 2 innovation centers in Brasil and Japan as well as in 6 R&D centers in France.
Thanks to our 9,600 employees in 44 subsidiaries and our distribution activities in 120 countries, our group generated €2.7 billion in revenues in 2022, 69% of which is from international business.
Pierre Fabre Group has a unique company structure.
86% of the Pierre Fabre Group is held by the Pierre Fabre Foundation, a government-recognized public-interest foundation, while a smaller share is owned by its employees via an employee stock ownership plan.
In 2020, the independent organization ECOCERT Environment awarded Pierre Fabre's CSR policy at "excellence" level : - Excellence being the highest maturity level of the ECOCERT 26000 standard.